Collegium Pharmaceutical, Inc SEC filings COLL
Collegium Pharmaceutical, Inc has 870 filings in SEC EDGAR's recent list, going back to Oct 20, 2003. Its latest annual report, Form ARS, was filed on Apr 7, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations, regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| DEF 14A | Proxy statement | Apr 7, 2026 | May 14, 2026 |
| DEFA14A | Additional proxy material | Mar 28, 2025 | — |
| DEF 14A | Proxy statement | Mar 28, 2025 | May 15, 2025 |
| DEFA14A | Additional proxy material | May 10, 2024 | — |
| DEFA14A | Additional proxy material | Apr 5, 2024 | — |
| DEF 14A | Proxy statement | Apr 5, 2024 | May 16, 2024 |
| DEF 14A | Proxy statement | Apr 11, 2023 | — |
| DEFA14A | Additional proxy material | Apr 6, 2022 | — |
| DEF 14A | Proxy statement | Apr 6, 2022 | May 19, 2022 |
| DEFA14A | Additional proxy material | Apr 7, 2021 | — |
| DEF 14A | Proxy statement | Apr 7, 2021 | May 20, 2021 |
| DEFA14A | Additional proxy material | Apr 9, 2020 | — |
| DEF 14A | Proxy statement | Apr 9, 2020 | May 20, 2020 |
| PRE 14A | Preliminary proxy statement | Mar 25, 2020 | May 20, 2020 |
| DEFA14A | Additional proxy material | Mar 15, 2019 | — |
| DEF 14A | Proxy statement | Mar 15, 2019 | Apr 25, 2019 |
| DEFA14A | Additional proxy material | Apr 13, 2018 | — |
| DEF 14A | Proxy statement | Apr 13, 2018 | May 24, 2018 |
| DEFA14A | Additional proxy material | Apr 14, 2017 | — |
| DEFA14A | Additional proxy material | Apr 13, 2017 | — |
| DEF 14A | Proxy statement | Apr 13, 2017 | May 24, 2017 |
| DEFA14A | Additional proxy material | Apr 29, 2016 | — |
| DEF 14A | Proxy statement | Apr 29, 2016 | Jun 9, 2016 |
Showing 23 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- COLL (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- VA
- Headquarters
- Stoughton, MA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1267565
- Former names
- COLLEGIUM PHARMACEUTICAL INC (until Mar 3, 2015)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.